Home › Heart Failure › Maryland
Heart Failure clinical trials in Maryland
28 studies for Heart Failure are looking for participants at sites in Maryland.
Cities in Maryland
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Annapolis
- Research Site, Baltimore
- Research Site, Lanham
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- University of Maryland Medical Center, Baltimore
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 24, 2026 · NCT06736574A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Ascension Saint Agnes Heart Care, Baltimore
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06424288A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Ascension Saint Agnes Heart Care, Baltimore
- Metropolitan Cardiovascular Consultants, Beltsville
- Capitol Cardiology Associates, Lanham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06935370Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Ascension Saint Agnes Heart Care, Baltimore
- Johns Hopkins University, Baltimore
- Metropolitan Cardiovascular Consultants LLC, Beltsville
- and 1 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 16, 2026 · NCT07037459Technical Development of Cardiovascular Magnetic Resonance Imaging
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Sep 15, 2026 · NCT04927429Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Baltimore
- Research Site, Beltsville
- Research Site, Lutherville-Timonium
- and 1 more
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 15, 2026 · NCT06677060Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Rockville
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 11, 2026 · NCT06307652A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Baltimore, MD Investigative Site 10101, Baltimore
- Bowie, MD Investigative Site 10020, Bowie
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06008197Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- University of Maryland Medical Center, Baltimore
- The Johns Hopkins Hospital, Baltimore
Recruiting
Ages 18 to 100 · All sexes · Updated Sep 9, 2026 · NCT06310031Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
Ages 7 to 100 · All sexes · Updated Sep 8, 2026 · NCT03581318A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 106, Baltimore
RecruitingPhase 2
Ages 30 to 84 · All sexes · Updated Aug 31, 2026 · NCT07795814Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Bethesda
- Hyattsville
- Salisbury
- and 1 more
RecruitingObservational study
All ages · All sexes · Updated Aug 20, 2026 · NCT00271180Rilonacept in Subjects With Cardiac Sarcoidosis
- Johns Hopkins University, Baltimore
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 20, 2026 · NCT06660732A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- MedStar Health Research Institute, Baltimore
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05489705A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Ascension Saint Agnes Heart Ca, Baltimore
- Mercy Medical Center, GI Research, Baltimore
- Flourish Research Bowie, Bowie
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001Alleviant ALLAY-HF Study
- Johns Hopkins Medical Institution, Baltimore
Recruiting
Ages 40 and older · All sexes · Updated Aug 14, 2026 · NCT05685303Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure
- Johns Hopkins Center for Health Equity, Baltimore
- Johns Hopkins University Comstock Center, Hagerstown
Recruiting
Ages 30 to 70 · All sexes · Updated Jul 15, 2026 · NCT06364644PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- MedStar, Baltimore
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05934487A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- Ascension Saint Agnes Heart Care, Baltimore
- Chesapeake Cardiac Care, Bowie
- Flourish Research - Bowie, Bowie
RecruitingPhase 2
Ages 18 to 79 · All sexes · Updated May 27, 2026 · NCT06991257The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Johns Hopkins, Baltimore
Recruiting
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT03142152Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
- Johns Hopkins University, Baltimore
RecruitingObservational studyHealthy volunteers welcome
Ages 30 and older · All sexes · Updated Apr 9, 2026 · NCT06517186Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism
- Johns Hopkins Medical Institutions, Baltimore
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Mar 9, 2026 · NCT00181259Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
- Johns Hopkins University, Baltimore
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT06932081Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
- University of Maryland Medical Center, Baltimore
- Johns Hopkins University School of Medicine, Baltimore
RecruitingObservational study
Ages 18 to 85 · All sexes · Updated Jan 20, 2026 · NCT00733590Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
- Johns Hopkins Hospital, Baltimore
RecruitingObservational study
Ages 18 to 90 · All sexes · Updated Jan 12, 2026 · NCT06299436Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
- Johns Hopkins University, Baltimore
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Feb 6, 2025 · NCT06228924Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- John Hopkins University School of Medicine, Baltimore
RecruitingObservational study
Ages 14 to 65 · All sexes · Updated Nov 1, 2024 · NCT06311708From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.